{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:48:08Z","timestamp":1792759688891,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.juro.2010.09.073","type":"journal-article","created":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T09:14:58Z","timestamp":1292663698000},"page":"445-449","source":"Crossref","is-referenced-by-count":95,"title":["Paclitaxel-Hyaluronic Acid for Intravesical Therapy of Bacillus Calmette-Gu\u00e9rin Refractory Carcinoma In Situ of the Bladder: Results of a Phase I Study"],"prefix":"10.1097","volume":"185","author":[{"given":"P.F.","family":"Bassi","sequence":"first","affiliation":[{"name":"Department of Urology, Catholic University School of Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Volpe","sequence":"additional","affiliation":[{"name":"Department of Urology, Catholic University School of Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"D'Agostino","sequence":"additional","affiliation":[{"name":"Department of Urology, Catholic University School of Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Palermo","sequence":"additional","affiliation":[{"name":"Department of Urology, Catholic University School of Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Renier","sequence":"additional","affiliation":[{"name":"Fidia Farmaceutici S.p.A. \u2013 Abano Terme, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Franchini","sequence":"additional","affiliation":[{"name":"Fidia Farmaceutici S.p.A. \u2013 Abano Terme, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rosato","sequence":"additional","affiliation":[{"name":"Department of Oncology and Surgical Sciences, University of Padova, and Istituto Oncologico Veneto IRCCS, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Racioppi","sequence":"additional","affiliation":[{"name":"Department of Urology, Catholic University School of Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2010.09.073_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/87.3.175","article-title":"Recent cancer trends in the United States","volume":"87","author":"Devesa","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2010.09.073_bib3","first-page":"5","article-title":"Introduction and overview of intravesical therapy for superficial bladder cancer","volume":"31","author":"Soloway","year":"1988","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.09.073_bib4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0090-4295(94)90134-1","article-title":"Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer","volume":"43","author":"Hasui","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.09.073_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.073_bib6","first-page":"3314","article-title":"Penetration of mitomycin C in human bladder","volume":"53","author":"Wientjes","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2010.09.073_bib7","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(00)02074-2","article-title":"The taxanes: an update","volume":"355","author":"Crown","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2010.09.073_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00345-006-0115-x","article-title":"State-of-the-art management of metastatic disease at initial presentation or recurrence","volume":"24","author":"Calabr\u00f2","year":"2006","journal-title":"World J Urol"},{"key":"10.1016\/j.juro.2010.09.073_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.eururo.2008.01.015","article-title":"The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials","volume":"53","author":"Sylvester","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.09.073_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.ju.0000162059.64886.1c","article-title":"Bacillus Calmette-Guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials","volume":"174","author":"Sylvester","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.073_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","article-title":"Bladder cancer","volume":"374","author":"Kaufman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2010.09.073_bib12","article-title":"Progetto HYTAD1-p20 (Coniugato chimico paclitaxel-acido ialuronico)","author":"Rosato","year":"2005","journal-title":"Department of Oncological and Surgical Sciences, Oncology Unit, University of Padua, Italy"},{"key":"10.1016\/j.juro.2010.09.073_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.nucmedbio.2009.02.005","article-title":"Biodistribution imaging of a paclitaxel-hyaluronan bioconjugate","volume":"36","author":"Banzato","year":"2009","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.juro.2010.09.073_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.urolonc.2005.08.020","article-title":"HYTAD1-p20: a new paclitaxel- hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer","volume":"24","author":"Rosato","year":"2006","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2010.09.073_bib15","article-title":"Assessing the residence time of HYTAD1-p20 in the vesical cavity by scintigraphy","author":"Rosato","year":"2004","journal-title":"Study Report, Department of Oncological and Surgical Sciences, Oncology Unit, University of Padua, Italy"},{"key":"10.1016\/j.juro.2010.09.073_bib16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.phrs.2008.09.008","article-title":"The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents","volume":"58","author":"Tringali","year":"2008","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.juro.2010.09.073_bib17","article-title":"Assessment of the loco-regional tolerability of HYTAD1-B in the bladder","author":"Rosato","year":"2004","journal-title":"Study Report, Department of Oncological and Surgical Sciences, Oncology Unit, University of Padua, Italy"},{"key":"10.1016\/j.juro.2010.09.073_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s002800050709","article-title":"Pharmacologic effects of paclitaxel in human bladder tumors","volume":"41","author":"Au","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.juro.2010.09.073_bib19","article-title":"Analysis of the pharmacokinetics and intravesical diffusion of HYTAD1-p20","author":"Rosato","year":"2004","journal-title":"Study Report, Department of Oncological and Surgical Sciences, Oncology Unit, University of Padua, Italy"},{"key":"10.1016\/j.juro.2010.09.073_bib20","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0022-5347(06)00264-3","article-title":"Complications of intravesical therapy for urothelial cancer of the bladder","volume":"175","author":"Koya","year":"2006","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710047063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710047063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2010.09.073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:44:56Z","timestamp":1651196696000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2010.09.073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1016\/j.juro.2010.09.073"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2010.09.073","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}